Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Radiopharmaceuticals (diagnostic use) - Gastrointestinal Transit

Terms

8Radiopharmaceuticals (diagnostic use)
5Gastrointestinal Transit
2Technetium Compounds (diagnostic use)
2Tin Compounds (diagnostic use)
2Pancreatin (administration & dosage)
2Delayed-Action Preparations
2Cystic Fibrosis (radionuclide imaging)
2Cystic Fibrosis (physiopathology)

Associations

Freq.WeightAssociation
22Gastrointestinal Transit - Tin Compounds (diagnostic use)
22Technetium Compounds (diagnostic use) - Tin Compounds (diagnostic use)
22Pancreatin (administration & dosage) - Tin Compounds (diagnostic use)
22Pancreatin (administration & dosage) - Technetium Compounds (diagnostic use)
22Gastrointestinal Transit - Technetium Compounds (diagnostic use)
22Gastrointestinal Transit - Radiopharmaceuticals (diagnostic use)
22Gastrointestinal Transit - Pancreatin (administration & dosage)
22Delayed-Action Preparations - Gastrointestinal Transit
22Cystic Fibrosis (radionuclide imaging) - Tin Compounds (diagnostic use)
22Cystic Fibrosis (radionuclide imaging) - Technetium Compounds (diagnostic use)
22Cystic Fibrosis (radionuclide imaging) - Pancreatin (administration & dosage)
22Cystic Fibrosis (radionuclide imaging) - Gastrointestinal Transit
22Cystic Fibrosis (physiopathology) - Tin Compounds (diagnostic use)
22Cystic Fibrosis (physiopathology) - Technetium Compounds (diagnostic use)
22Cystic Fibrosis (physiopathology) - Pancreatin (administration & dosage)
22Cystic Fibrosis (physiopathology) - Gastrointestinal Transit
22Cystic Fibrosis (physiopathology) - Cystic Fibrosis (radionuclide imaging)

Documents par ordre de pertinence
000064 (1998) P G Hillel (Royaume-Uni) ; W B Tindale ; C J Taylor ; M Frier ; S Senior ; S GhosalThe use of dual-isotope imaging to compare the gastrointestinal transit of food and pancreatic enzyme pellets in cystic fibrosis patients.
000060 (1999) C J Taylor (Royaume-Uni) ; P G Hillel ; S Ghosal ; M Frier ; S Senior ; W B Tindale ; N ReadGastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis.
000058 (2000) S J Wang (République de Chine (Taïwan)) ; S C Tsai ; W Y Lin ; G H ChenA simple method for preparing radioactive capsules in colon transit study.
000112 (1987) J G Hardy ; J N Healey ; S W Lee ; J R ReynoldsGastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet.
000010 (2012) Wengen Chen (États-Unis) ; Vasken DilsizianMolecular imaging of amyloidosis: will the heart be the next target after the brain?
000027 (2009) Hala M Fadda (Royaume-Uni) ; Emma L McConnell ; Michael D Short ; Abdul W BasitMeal-induced acceleration of tablet transit through the human small intestine.
000041 (2005) Peter S Conti (États-Unis) ; Christine White ; Peter Pieslor ; Arturo Molina ; Jacqueline Aussie ; Paul FosterThe role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry.
000050 (2002) Christophe Van de Wiele (Belgique) ; Alberto Signore ; Rudi Andre DierckxPeptide receptor imaging: advances in the diagnosis of pulmonary diseases.
000051 (2002) Vikas Kundra (États-Unis) ; Finn Mannting ; Alun G Jones ; Amin I KassisNoninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer.
000067 (1998) P J Bohdiewicz (États-Unis)Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging.
000069 (1998) S Heyman (États-Unis)Gastric emptying in children.

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014